Old Port Advisors Cuts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Old Port Advisors reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 3.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,060 shares of the healthcare conglomerate’s stock after selling 43 shares during the period. Old Port Advisors’ holdings in UnitedHealth Group were worth $544,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in UNH. New World Advisors LLC purchased a new position in UnitedHealth Group in the third quarter valued at approximately $319,000. MFA Wealth Advisors LLC acquired a new stake in UnitedHealth Group in the third quarter valued at approximately $126,000. Captrust Financial Advisors grew its position in UnitedHealth Group by 17.0% in the third quarter. Captrust Financial Advisors now owns 97,035 shares of the healthcare conglomerate’s stock valued at $37,915,000 after acquiring an additional 14,113 shares in the last quarter. Summit Trail Advisors LLC grew its position in UnitedHealth Group by 21.1% in the third quarter. Summit Trail Advisors LLC now owns 1,058 shares of the healthcare conglomerate’s stock valued at $413,000 after acquiring an additional 184 shares in the last quarter. Finally, Studio Investment Management LLC acquired a new stake in UnitedHealth Group in the third quarter valued at approximately $3,534,000. Institutional investors and hedge funds own 87.48% of the company’s stock.

UNH stock opened at $489.68 on Thursday. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29. The stock’s fifty day moving average is $496.56 and its two-hundred day moving average is $490.86. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.78 and a current ratio of 0.78. The stock has a market capitalization of $459.40 billion, a price-to-earnings ratio of 26.80, a PEG ratio of 1.41 and a beta of 0.83.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its quarterly earnings data on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share for the quarter, beating analysts’ consensus estimates of $5.40 by $0.09. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The business had revenue of $80.15 billion for the quarter, compared to analysts’ expectations of $78.77 billion. During the same period in the previous year, the business earned $5.31 earnings per share. The company’s revenue was up 14.2% on a year-over-year basis. As a group, analysts predict that UnitedHealth Group Incorporated will post 21.75 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 28th. Investors of record on Monday, June 20th will be issued a dividend of $1.65 per share. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.45. This represents a $6.60 dividend on an annualized basis and a yield of 1.35%. The ex-dividend date is Thursday, June 16th. UnitedHealth Group’s payout ratio is presently 36.12%.

In related news, Director Frederick William Mcnabb III purchased 89 shares of the company’s stock in a transaction that occurred on Thursday, May 26th. The shares were purchased at an average price of $504.32 per share, with a total value of $44,884.48. Following the purchase, the director now owns 11,259 shares of the company’s stock, valued at approximately $5,678,138.88. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction dated Thursday, May 19th. The stock was sold at an average price of $478.96, for a total value of $1,197,400.00. Following the completion of the transaction, the director now directly owns 1,215,000 shares in the company, valued at approximately $581,936,400. The disclosure for this sale can be found here. 0.40% of the stock is owned by insiders.

UNH has been the subject of several recent research reports. Credit Suisse Group increased their price objective on shares of UnitedHealth Group from $564.00 to $595.00 and gave the company an “outperform” rating in a research report on Monday, April 18th. StockNews.com initiated coverage on shares of UnitedHealth Group in a research report on Thursday, March 31st. They set a “strong-buy” rating for the company. Royal Bank of Canada set a $563.00 price target on shares of UnitedHealth Group and gave the stock an “outperform” rating in a research report on Monday, April 18th. Raymond James raised their price target on shares of UnitedHealth Group from $540.00 to $620.00 and gave the stock a “strong-buy” rating in a research report on Tuesday, April 19th. Finally, Barclays raised their price target on shares of UnitedHealth Group from $495.00 to $565.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 30th. Three analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $555.73.

About UnitedHealth Group (Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.